{"id":"https://openalex.org/W2407090338","doi":null,"title":"Anti-invasive activity of synthetic serine protease inhibitors and its combined effect with a matrix metalloproteinase inhibitor.","display_name":"Anti-invasive activity of synthetic serine protease inhibitors and its combined effect with a matrix metalloproteinase inhibitor.","publication_year":1998,"publication_date":"1998-11-01","ids":{"openalex":"https://openalex.org/W2407090338","mag":"2407090338","pmid":"https://pubmed.ncbi.nlm.nih.gov/9891476"},"language":"en","primary_location":{"id":"pmid:9891476","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9891476","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074925412","display_name":"Takashi Ikeda","orcid":"https://orcid.org/0000-0003-3976-5230","observed_orcids":["https://orcid.org/0000-0003-3976-5230"]},"institutions":[{"id":"https://openalex.org/I42766147","display_name":"University of Toyama","ror":"https://ror.org/0445phv87","country_code":"JP","type":"education","lineage":["https://openalex.org/I42766147"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"T Ikeda","raw_affiliation_strings":["Department of Pathogenic Biochemistry, Toyama Medical and Pharmaceutical University, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathogenic Biochemistry, Toyama Medical and Pharmaceutical University, Japan","institution_ids":["https://openalex.org/I42766147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111489525","display_name":"Kosuke Murakami","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Murakami","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012119811","display_name":"Yoshihiro Hayakawa","orcid":"https://orcid.org/0000-0002-7921-1171","observed_orcids":["https://orcid.org/0000-0002-7921-1171"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y Hayakawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004551224","display_name":"H. Fujii","orcid":"https://orcid.org/0000-0002-0049-0084","observed_orcids":["https://orcid.org/0000-0002-0049-0084"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H Fujii","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109359545","display_name":"Motohiro Ohkoshi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Ohkoshi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031016906","display_name":"Isao SAIKI","orcid":"https://orcid.org/0000-0002-9705-6857","observed_orcids":["https://orcid.org/0000-0002-9705-6857"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I Saiki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4095,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.61076453,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"18","issue":"6A","first_page":"4259","last_page":"65"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13437","display_name":"Mechanisms of cancer metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serine-protease-inhibitors","display_name":"serine protease inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.8230000138282776},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6169999837875366},{"id":"https://openalex.org/keywords/urokinase-type-plasminogen-activator","display_name":"urokinase","score":0.953000009059906},{"id":"https://openalex.org/keywords/matrix-metalloproteinase-inhibitors","display_name":"matrix metalloproteinase inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/anti-invasive-activity","display_name":"anti-invasive activity","score":0.7179999947547913},{"id":"https://openalex.org/keywords/ht1080-fibrosarcoma-cells","display_name":"HT1080 fibrosarcoma cells","score":0.9079999923706055},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6959999799728394}],"concepts":[{"id":"https://openalex.org/C2777807008","wikidata":"https://www.wikidata.org/wiki/Q87324999","display_name":"Serine protease","level":4,"score":0.6595208048820496},{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.6310451030731201},{"id":"https://openalex.org/C182220744","wikidata":"https://www.wikidata.org/wiki/Q7251226","display_name":"Proteases","level":3,"score":0.6217243671417236},{"id":"https://openalex.org/C2775958869","wikidata":"https://www.wikidata.org/wiki/Q16966320","display_name":"Matrix metalloproteinase inhibitor","level":3,"score":0.5478394627571106},{"id":"https://openalex.org/C2778608917","wikidata":"https://www.wikidata.org/wiki/Q6787805","display_name":"Matrigel","level":3,"score":0.5467478632926941},{"id":"https://openalex.org/C109523444","wikidata":"https://www.wikidata.org/wiki/Q424216","display_name":"Matrix metalloproteinase","level":2,"score":0.47370216250419617},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4661126732826233},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.4392378032207489},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41671067476272583},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.4122886657714844},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38855481147766113},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.38274669647216797},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37417638301849365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36988750100135803},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3211081624031067},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.20365974307060242},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.15350380539894104},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.08780291676521301}],"mesh":[{"descriptor_ui":"D000501","descriptor_name":"Allylglycine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000501","descriptor_name":"Allylglycine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000578","descriptor_name":"Amidines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D001550","descriptor_name":"Benzamidines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D001565","descriptor_name":"Benzoates","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004952","descriptor_name":"Esters","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005354","descriptor_name":"Fibrosarcoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006146","descriptor_name":"Guanidines","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014568","descriptor_name":"Urokinase-Type Plasminogen Activator","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D015842","descriptor_name":"Serine Proteinase Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D016670","descriptor_name":"Gabexate","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9891476","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9891476","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Journal Article"},{"id":"mag:2407090338","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9891476","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2133784954","https://openalex.org/W2470712598","https://openalex.org/W2064534129","https://openalex.org/W2124256512","https://openalex.org/W2094070957","https://openalex.org/W2130821225","https://openalex.org/W2001691111","https://openalex.org/W1986395837","https://openalex.org/W2078358345","https://openalex.org/W2126635241"],"abstract_inverted_index":{"Tumor":[0],"invasion":[1,102,113,174],"into":[2,117],"the":[3,22,27,32,74,82,112,118,136,150,173,181,194],"extracellular":[4],"matrix":[5],"(ECM)":[6],"and":[7,67,95,103,130,159,187],"basement":[8],"membrane":[9],"(BM)":[10],"is":[11,90,142],"a":[12,42,197],"crucial":[13],"step":[14],"of":[15,35,76,84,92,114,139,153,166,175,184],"tumor":[16,28,101,176,185],"metastasis.":[17],"In":[18,148,169],"order":[19],"to":[20,60,97],"investigate":[21],"possible":[23],"therapeutic":[24],"procedure":[25],"for":[26],"invasion,":[29],"we":[30],"investigated":[31],"anti-invasive":[33,137,158,167],"activities":[34,72],"several":[36],"synthetic":[37],"serine":[38,43,93],"protease":[39,44],"inhibitors.":[40],"FOY-305,":[41],"inhibitor,":[45],"showed":[46,69],"no":[47],"cytotoxic":[48,71],"activity":[49,83,138,183,190],"against":[50],"human":[51],"HT-1080":[52,115],"fibrosarcoma":[53],"cells":[54,116,177],"at":[55,73],"concentrations":[56],"ranging":[57],"from":[58],"0.1":[59],"100":[61,77],"micrograms/ml,":[62],"while":[63],"its":[64],"analogs":[65],"ONO-3403":[66,129],"FO-349":[68],"slight":[70],"concentration":[75],"micrograms/ml.":[78],"These":[79,132],"compounds":[80,141],"inhibited":[81,111,124,172],"urokinase-type":[85],"plasminogen":[86],"activator":[87],"(u-PA)":[88],"which":[89],"one":[91],"proteases":[94],"considered":[96],"be":[98],"associated":[99],"with":[100,128,144,155,180,196],"metastasis":[104],"in":[105,163],"fibrin":[106],"zymography.":[107],"FOY-305":[108,154,171],"more":[109],"potently":[110],"reconstituted":[119],"BM":[120],"Matrigel,":[121],"as":[122],"well":[123],"u-PA":[125,182],"activity,":[126],"compared":[127],"FO-349.":[131],"results":[133],"suggest":[134],"that":[135],"these":[140],"consistent":[143],"their":[145],"anti-fibrinolytic":[146],"activities.":[147],"addition,":[149],"combined":[151],"treatment":[152],"FC-336":[156],"processing":[157],"anti-MMP":[160],"properties":[161],"resulted":[162],"marked":[164],"enhancement":[165],"activity.":[168],"conclusion,":[170],"through":[178],"interference":[179],"cells,":[186],"this":[188],"inhibitory":[189],"was":[191],"augmented":[192],"by":[193],"combination":[195],"MMP":[198],"inhibitor.":[199]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}